Literature DB >> 33343695

Detection of additional abnormalities or co-morbidities in women with suspected intrahepatic cholestasis of pregnancy.

Frances Conti-Ramsden1, Michael McEwan2, Rachel Hill1, Julie Wade1, Georgina Abraham1, Olivia Buckeldee2, Catherine Williamson1, Caroline L Knight1, Joanna Girling2, Lucy C Chappell1.   

Abstract

BACKGROUND: Current guidelines recommend viral, autoimmune, coagulation and liver ultrasound testing in intrahepatic cholestasis of pregnancy to exclude alternative diagnoses.
METHODS: Electronic health records were searched for investigations and diagnoses in women with raised bile acid concentrations (>10 µmol/L) between January 2016 and December 2017 at two UK maternity units.
RESULTS: Five hundred and thirty-one women had a raised bile acid concentration (median (IQR): 18 (13-32 µmol/L)) at a median gestation of 35.1 (IQR 31.8-37.0) weeks. Out of 531 women, 250 (47.1%) had full virology, autoimmune and ultrasound tests, and 348 (65.5%) had coagulation performed. Positive hepatitis B and C results were previously known. No new Epstein-Barr virus, cytomegalovirus or hepatitis A diagnoses were made. There were 11 positive autoimmune results, but no new diagnoses. No woman had an unexplained prolonged prothrombin time. No ultrasound liver (n = 38) or gallbladder (n = 85) abnormalities were of acute clinical significance.
CONCLUSION: Intrahepatic cholestasis of pregnancy investigations provided no new diagnoses that influenced clinical management during pregnancy.
© The Author(s) 2019.

Entities:  

Keywords:  Cholestasis; pregnancy

Year:  2019        PMID: 33343695      PMCID: PMC7726172          DOI: 10.1177/1753495X19868873

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  11 in total

1.  Intrahepatic cholestasis of pregnancy: a French prospective study.

Authors:  Y Bacq; T Sapey; M C Bréchot; F Pierre; A Fignon; F Dubois
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

Review 2.  Management of intrahepatic cholestasis of pregnancy.

Authors:  Hanns-Ulrich Marschall
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-08-27       Impact factor: 3.869

3.  Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis.

Authors:  A P Kenyon; R M Tribe; C Nelson-Piercy; J C Girling; C Williamson; P T Seed; S Vaughan-Jones; A H Shennan
Journal:  Obstet Med       Date:  2010-03-04

4.  Pregnancy outcome with intrahepatic cholestasis.

Authors:  S Heinonen; P Kirkinen
Journal:  Obstet Gynecol       Date:  1999-08       Impact factor: 7.661

5.  Obstetric cholestasis, outcome with active management: a series of 70 cases.

Authors:  Anna P Kenyon; C Nelson Piercy; J Girling; C Williamson; R M Tribe; A H Shennan
Journal:  BJOG       Date:  2002-03       Impact factor: 6.531

6.  Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution.

Authors:  P Abedin; J B Weaver; E Egginton
Journal:  Ethn Health       Date:  1999 Feb-May       Impact factor: 2.772

7.  The clinical utility of a positive antinuclear antibody test result.

Authors:  Aryeh M Abeles; Micha Abeles
Journal:  Am J Med       Date:  2013-02-08       Impact factor: 4.965

Review 8.  The pathophysiology of intrahepatic cholestasis of pregnancy.

Authors:  Peter H Dixon; Catherine Williamson
Journal:  Clin Res Hepatol Gastroenterol       Date:  2016-01-25       Impact factor: 2.947

9.  Serum bile acids in liver disease.

Authors:  G Neale; B Lewis; V Weaver; D Panveliwalla
Journal:  Gut       Date:  1971-02       Impact factor: 23.059

10.  An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy.

Authors:  Peter H Dixon; Melissa Sambrotta; Jennifer Chambers; Pamela Taylor-Harris; Argyro Syngelaki; Kypros Nicolaides; A S Knisely; Richard J Thompson; Catherine Williamson
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

View more
  1 in total

1.  Obeticholic acid improves fetal bile acid profile in a mouse model of gestational hypercholanemia.

Authors:  Vanessa Pataia; Saraid McIlvride; Georgia Papacleovoulou; Caroline Ovadia; Julie A K McDonald; Annika Wahlström; Eugène Jansen; Luciano Adorini; David Shapiro; Julian R Marchesi; Hanns-Ulrich Marschall; Catherine Williamson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-06-29       Impact factor: 4.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.